Home Cellcept Tablets 500mg
Cellcept Tablets 500mg by Roche — Mycophenolate Mofetil Immunosuppressant
Acicon 20mg Famotidine H2 Blocker — Gastric Ulcer and Acid Reflux Medicine Pakistan
Cellcept Tablets 500mg by Roche — Mycophenolate Mofetil Immunosuppressant
Acicon 20mg Famotidine H2 Blocker — Gastric Ulcer and Acid Reflux Medicine Pakistan

Cellcept Tablets 500mg

Cellcept 500mg (Mycophenolate Mofetil) is a prescription immunosuppressant by Roche indicated for the prophylaxis of acute rejection in renal, cardiac, and hepatic transplant patients. It is used in combination with ciclosporin and corticosteroids under specialist supervision. Regular haematological monitoring is required during treatment.

Sale price Rs. 8,147

Pay in 3 Installments of

Rs.

3123

Availability: In stock SKU: derma.pk-5457-109-016
Tags: Cellcept 500mg Heart Transplant Immunosuppressant Kidney Transplant Liver Transplant Mycophenolate Mofetil Organ Transplant Medicine Prescription Medicine Roche Cellcept Transplant Rejection Prevention
Cellcept Tablets 500mg by Roche — Mycophenolate Mofetil Immunosuppressant

Cellcept Tablets 500mg

Rs. 8,147

Cellcept Tablets 500mg — Mycophenolate Mofetil

Cellcept Tablets 500mg (Mycophenolate Mofetil) is an original Roche immunosuppressive medicine indicated for the prophylaxis of acute organ rejection in adult patients receiving allogeneic renal, cardiac, or hepatic transplants. It is used in combination with ciclosporin and corticosteroids as part of a standard immunosuppressive protocol.

Mycophenolate Mofetil inhibits inosine monophosphate dehydrogenase (IMPDH), selectively suppressing T- and B-lymphocyte proliferation by blocking de novo purine synthesis. This targeted mechanism reduces the immune response responsible for transplant rejection without the nephrotoxicity associated with calcineurin inhibitors.

  • Prophylaxis of acute rejection in renal, cardiac, and hepatic transplant patients
  • Selective inhibition of lymphocyte proliferation via IMPDH blockade
  • Used in combination with ciclosporin and corticosteroids
  • Original Roche formulation — clinical-grade quality and consistency
  • Requires regular haematological monitoring including full blood counts

Dosage and Administration

Administer Cellcept only under the supervision of a physician experienced in immunosuppressive therapy and transplant management. The typical dose for renal transplant is 1g twice daily (2g/day). Cardiac and hepatic transplant protocols use 1.5g twice daily (3g/day). Dosage must be individualised based on clinical response and haematological tolerability. Swallow tablets whole; do not crush. Regular CBC monitoring is essential to detect leucopenia or other haematological effects.

Refer to related Rx medicines on Derma.pk: Alphagan Eye Drops 0.2% 5ml and Aerokast Tablets 10mg.

Usage & Benefits
  • Prevents acute organ rejection following kidney, heart, and liver transplants
  • Selectively suppresses lymphocyte proliferation via IMPDH inhibition
  • Reduces transplant rejection risk when combined with ciclosporin and corticosteroids
  • Original Roche formulation providing consistent clinical-grade quality
  • Established component of standard post-transplant immunosuppressive protocols
How To Use

Cellcept must only be administered under the direct supervision of a physician specialised in immunosuppressive therapy and organ transplant management. Swallow tablets whole with water; do not crush, chew, or split. Doses are typically taken twice daily with or without food. Follow the exact dosing schedule prescribed by your transplant physician. Regular full blood count monitoring is mandatory throughout treatment.

FAQs

What is Cellcept 500mg used for?

Cellcept 500mg is a prescription immunosuppressant used to prevent acute organ rejection in patients who have received a kidney, heart, or liver transplant. It must be used under specialist medical supervision.

Is Cellcept available over the counter?

No. Cellcept is a prescription-only medicine. A valid prescription from a qualified transplant physician is required to obtain this medication.

What monitoring is required during Cellcept treatment?

Regular haematological monitoring including complete blood counts (CBC) is required to detect potential side effects such as leucopenia, anaemia, or thrombocytopenia. Follow your physician's monitoring schedule.